Wells Criteria for Pulmonary Embolism
The Wells score for PE is a validated clinical decision tool that assigns points to seven clinical variables to stratify patients into low, intermediate, or high probability categories, guiding the need for D-dimer testing and imaging. 1
Wells Score Components and Point Values
The Wells score includes the following seven variables:
- Clinical symptoms of DVT (leg swelling, pain with palpation): 3 points
- PE more likely than other diagnoses: 3 points
- Heart rate >100 bpm: 1.5 points
- Immobilization ≥3 days or surgery in the previous 4 weeks: 1.5 points
- Previous DVT or PE: 1.5 points
- Hemoptysis: 1 point
- Cancer (active or treated within 6 months): 1 point
Interpretation and Clinical Application
Standard Wells Scoring (3-Level):
- Low probability: <2 points
- Moderate probability: 2-6 points
- High probability: >6 points
Modified Wells Scoring (2-Level):
- PE unlikely: ≤4 points
- PE likely: >4 points
Algorithmic Approach to Using Wells Score
For patients with Wells score ≤4 (PE unlikely):
- Obtain D-dimer testing
- If D-dimer is negative (using age-adjusted threshold of age × 10 μg/L for patients >50 years, or standard <500 μg/L), PE is safely excluded without imaging
- If D-dimer is positive, proceed to CT pulmonary angiography
For patients with Wells score >4 (PE likely) or high probability (>6):
- Proceed directly to imaging (CTPA) without D-dimer testing, as a negative D-dimer will not obviate the need for imaging 1, 2
Critical Clinical Nuances
The "PE more likely than other diagnoses" criterion requires clinical judgment and represents a key difference from the Revised Geneva Score, which uses only objective variables. This subjective component has been validated but requires the clinician to assess whether PE is the most probable diagnosis compared to alternative explanations for the patient's presentation. 1
Important caveat: The Wells score combined with D-dimer strategies has been validated primarily in patients not on therapeutic anticoagulation at baseline. Most validation studies excluded anticoagulated patients, so exercise caution when applying these criteria to patients already on anticoagulation. 1
Evidence Quality and Safety
The Wells score has been extensively validated with a failure rate (missed PE at 3 months) consistently below the accepted 2% safety threshold. When combined with age-adjusted D-dimer in patients with low or intermediate probability, the 3-month VTE rate is approximately 0.3-0.5%, confirming the safety of withholding imaging in this population. 1, 3, 4, 5
The Wells score performs better than the Revised Geneva Score in certain populations, particularly when combined with D-dimer testing, with higher specificity while maintaining excellent sensitivity. 6